Search for: "Inform Inc. v. Google LLC et al" Results 61 - 80 of 113
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jun 2019, 5:30 am by Barry Sookman
F.C. 20 December, 2018 Australasian Performing Right Association Ltd v Telstra Corporation Limited [2019] FCA 751 (stream ripping sites) S.A.S Elsevier et al v S.A. [read post]
10 May 2020, 3:15 am by Barry Sookman
Live streaming providers as ‘online content sharing service providers’ und… https://t.co/gzsXkBVw5r 2020-05-08 Fair dealing defence made out for documentary, Wiseau Studio, LLC et al. v. [read post]
26 Jan 2015, 4:03 am
Circuit Court of Appeals in Pom Wonderful LLC v Hubbard et al | Biotech inventions: controversies, case law, uncertainties and financing.Never too late 26 [week ending Sunday 28 December] -- Arnold J on Ice cream van design in Whitby Specialist Vehicles v Yorkshire Specialist Vehicles | Adios to positive right of TM in Spain | Costs of Vestergaard Fransen v Bestnet Europe | Irish PTO on slogan TMs |… [read post]
12 Feb 2010, 3:17 am
Traffic Information LLC(Docket Report) District Court E D Virginia: Cookies-functional web browser was ready for patenting when initial draft of source code was logged into repository: Netscape Communications Corp., v. [read post]
5 Oct 2017, 2:07 pm by Daphne Keller
We have not seen studies or significant public data on this question, though there will be useful information in the study just published by Urban, et al.[1] Based on our own experience and discussion with other practitioners, we believe that it is rare for users to file counter-notices. [read post]
21 Jan 2016, 9:19 am by Venkat Balasubramani
Luckey went on to form Oculus, LLC, and develop Rift, which became a blockbuster on Kickstarter and was ultimately sold to Facebook for 8 figures. [read post]
13 Nov 2007, 9:01 pm
Deutsche Telekom AG et al, which involves 131 defendants (see post here). [read post]
2 Feb 2015, 2:20 am
Suleman reviews Case C‑631/13, Arne Forsgren v Österreichisches Patentamt, a decision where the CJEU addressed the issues of whether a Supplementary Protection Certificate (SPC) could be obtained for a product per se in ‘separate’ form when the marketing authorisation was for a medicine in which the product is covalently bonded to other ingredients and whether a SPC could rely on a marketing authorisation which only described the… [read post]